The prescription drug Xarelto has recently been linked to uncontrollable bleeding which result in the need for hospitalization, serious injury or death. Because of the terrible side effect, there are over 400 Xarelto lawsuit filed in the federal MDL and it will continue to rise in the coming months. If you are considering filing a Xarelto lawsuit, read the following points to understand the litigation more.
- The FDA approved Xarelto was initially approved for preventing blood clots and DVT in patients who underwent hip or knee replacement surgeries. It was also approved to prevent blood clots in patients who suffer from atrial fibrillation. A more recent approval was for the general reduction of incidents of blood clots in patients who suffer from acute coronary syndrome.
- In 2011, Xarelto was approved for sale in the United States for the first time. The European drug conglomerate, Bayer AG, who has operations in the U.S, manufactured it along with Johnson & Johnson.
- The manufacturers of the drug have not advised the medical community as to a reversal of the effects of Xarelto. There have been reports that a startup company has found a reversal agent, however it has not been approved.
- When Xarelto was being tested, a study revealed that more than 16,000 subjects reported an adverse side effect.
- The FDA has issued a warning that the premature discontinuance of Xarelto increases the risk of blood clots.
- In January 2014, the first Xarelto lawsuit was filed. The claim alleges that the drug caused uncontrollable bleeding that lead to the death of the plaintiff’s husband. Since then, hundreds of lawsuits have been filed. All have an unfortunate common theme – uncontrollable bleeding that lead to a serious injury, hospitalization or death.
- The most common injuries named in lawsuits are: pulmonary embolism, heart attack, stroke, brain hemorrhage, rectal bleeding, vaginal bleeding, epidural hematoma and gastrointestinal bleeding.
- Because there are so many federal lawsuits, a mechanism known as MDL was formed to streamline the pretrial and discovery phases of the litigation. For federal cases, they will be transferred to the federal court in Louisiana. In addition to that, many lawsuits were filed in Pennsylvania and the court of common pleas have followed a similar strategy to process the discovery and pretrial motions via a consolidated mass tort group.
If you or a loved one took Xarelto and suffered from uncontrollable bleeding leading to hospitalization, serious injury or death, you deserve compensation. If you think you have a case, sign up for a free case evaluation with us to determine your eligibility by clicking here. For more information about Xarelto, visit us at DrugResource.com or call us at 888-353-8348.